Health. A male contraceptive gel could be released.

Men may soon have a new, reliable method of contraception. Contraline is developing a male contraceptive implant. The product has completed the first phase of clinical trials with encouraging results.

The Adam implant is made of hydrogel, an insoluble polymer that prevents sperm from reaching the prostate. The man can still ejaculate, but his semen no longer contains sperm. According to the initial results of clinical trials conducted on 25 participants, the contraceptive gel, which is injected into the scrotum, is effective for two years, after which it dissolves naturally, allowing the user to regain fertility.

An alternative to vasectomy

The results have not yet been published in a scientific journal, which is necessary for them to be validated within the scientific community. The second phase of clinical trials is expected to begin later this year in Australia with 30 to 50 participants.

This non-invasive contraceptive still needs to prove its effectiveness and obtain the necessary approvals before being marketed. It could be an alternative to condoms or vasectomies, which are non-reversible in most cases.

Today, contraception relies primarily on women, who have a wide range of contraceptive options at their disposal. Conversely, men have few alternatives while waiting for other treatments currently under study to reach the market.